## **Learning Outcomes**

By the end of this session, you should be able to:

1. Define **Surgical Site Infection (SSI)** and understand its significance.
    
2. Appreciate the **historical development** of infection control.
    
3. Understand the **basics of wound healing** and recognise **clinical signs** of SSI.
    
4. Identify **risk factors** and **causative microorganisms**.
    
5. Describe preventive measures in **pre-, intra-, and postoperative** care.
    
6. Recognise the importance of **device-associated** and **prosthetic joint infections (PJI)**.
    

---

## **1. Definition**

**Surgical Site Infection (SSI):**  
Infection occurring **in an incision** or **operative wound** made during an **invasive surgical procedure**, within:

- **30 days** post-surgery, or
    
- **1 year** if a **prosthetic device** is implanted.
    

---

## **2. Why Are SSIs Important?**

- Account for **~20 %** of hospital-acquired infections (HCAIs).
    
- Cause **prolonged hospital stay**, **morbidity**, and increased **costs**.
    
- Risk varies by **wound classification (clean â†’ dirty)**.
    
- **Prevention > cure** â€” once infection develops, management is complex.
    

---

## **3. Historical Background**

|Era|Key Developments|
|---|---|
|**Pre-1860s**|Post-operative sepsis caused >50 % mortality (e.g., amputation â†’ 60 % death).|
|**1860s â€“ Lister**|Introduced **antiseptic technique** using carbolic acid spray.|
|**Late 1800s â€“ Ogston, Pasteur**|Germ theory & recognition of _Staphylococcus aureus_ as major wound pathogen.|

ðŸ§  **Exam Focus:** Name **Joseph Lister** and **Louis Pasteur** as pioneers who established the microbial basis of surgical infection control.

---

## **4. Wound Healing Basics**

### **Phases**

1. **Haemostasis:** clot formation.
    
2. **Inflammation:** neutrophil & macrophage infiltration.
    
3. **Proliferation:** fibroblast activity, angiogenesis, granulation tissue.
    
4. **Remodelling:** collagen maturation and scar formation.
    

---

## **5. Clinical Signs of Infection**

### **Local signs**

- **Rubor** (redness/erythema)
    
- **Calor** (warmth)
    
- **Tumor** (swelling)
    
- **Dolor** (pain)
    
- **Loss of function**
    

### **Wound features**

- **Erythema**, **purulent discharge**, **failure to heal**
    
- **Fluctuant collection**, **dehiscence**, **abscess formation**
    

### **Systemic signs**

- **Fever**, **malaise**, **tachycardia**, possible **sepsis**.
    

---

## **6. Clinical Presentation**

Severity varies from mild inflammation to severe necrosis.

| Type         | Examples                                                                                                                                                                                      |
| ------------ | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Mild**     | Serous wound discharge, delayed healing                                                                                                                                                       |
| **Moderate** | Purulent exudate, local abscess                                                                                                                                                               |
| **Severe**   | - Dehiscence (when a wound does not close by itself, it starts swelling from the inside - causing tissue to 'erupt' out), <br>- necrosis, **necrotising fasciitis**, **gangrene**, **sepsis** |

ðŸ©¸ **Consequences:** bacterial spread â†’ **bacteraemia**, **sepsis**, infection of **heart valves, joints, CNS**, or **peritoneum**.

---

## **7. Pathogenesis â€“ How, Why, When**

SSIs occur when:

- **Normal skin flora contaminate incision**, or
    
- **Tissue damage** + **foreign bodies** (sutures, implants) reduce defence.
    

### **Timing of contamination**

- **Pre-operative:** colonisation, poor prep.
    
- **Intra-operative:** breaks in sterile field, poor technique.
    
- **Post-operative:** dressing disruption, poor wound care.
    

---

## **8. Microbial Causes**

|Site|Common Pathogens|
|---|---|
|**Skin**|_Staphylococcus aureus_, _Streptococci spp._, _Enterococci spp._|
|**Bowel**|_E. coli_, _Bacteroides fragilis_, _Clostridium perfringens_, _Enterococci spp._, anaerobic cocci|

ðŸ§« **Polymicrobial infections** common in **contaminated or dirty wounds**.

---

## **9. Classification of Surgical Wounds**

| Class (cfu = colony forming unit)           | Description                                                                                                                                                              | Typical Infection Rate (â‰ˆ) (without antibiotic prophylaxis and with) |
| ------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | -------------------------------------------------------------------- |
| **I â€“ Clean**<br>< 10 cfu/ml                | - Elective, no acute inflamation, no entry to GI/GU/resp tract                                                                                                           | 2 % (2%)                                                             |
| **II â€“ Clean-contaminated**<br>20-40 cfu/ml | - Urgent/emergency case, clean wounds with higher risk of infection<br>- Uncomplicated respiratory, GI or GU tract surgery                                               | 6â€“9 % (3-4%)                                                         |
| **III â€“ Contaminated**<br>1000-1500 cfu/ml  | - Gross spillage or major technique break<br>- Outside objects comes into contact with wound<br>- Large amounts of spillage from GI tract into wound                     | 13â€“20 % (6-7%)                                                       |
| **IV â€“ Dirty**<br>>3500 cfu/ml              | - Purulent inflammation (formation of inflammation)<br>- Foreign object lodged in wound<br>- Traumatic or infected wounds<br>- Pre-existing infection or necrotic tissue | 40 % (7-16%)                                                         |

**With prophylactic antibiotics**, infection rates drop markedly (Class IV â†’ ~7â€“16 %).

---

## **10. Risk Factors for SSI**

| Category              | Examples                                                                                                                                                                              |
| --------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Patient-related**   | Diabetes, obesity, smoking, malnutrition, immunosuppression, anaemia, age, prolonged pre-op stay, ethicity (arguably)                                                                 |
| **Procedure-related** | Emergency surgery, long duration, contaminated field, poor haemostasis. poor closure of wound, insertion of surgical drain, tissue handling, preoperative shaving or site of incision |
| **Environmental**     | Theatre ventilation, instrument sterility, hand hygiene failures                                                                                                                      |

---

## **11. Factors Affecting Development of SSIs**

#### **How, Why and When do SSIs Occur?**
- Contamination of incision by normal microbiota
- Damage to tissues
- Damage to blood vessels
- Presence of foreign bodies (e.g. sutures, implants)
- Reduced efficacy of inflammatory response
- Contamination can occur before, during and after the surgery

#### **Microbial Causes of SSIs**
###### **Skin**
- Staphylococcus aureus
- Streptococci spp.
- Enterococci spp.

##### **Bowel**
- E.coli
- Bacteroides fragilis
- Clostridium perfringens
- Enterococci spp.
- Anaerobic cocci

### **A. Pre-operative**

- **MRSA screening** (+ eradication if positive).
    
- **Pre-op showering** with antiseptic.
    
- **Hair removal** only immediately before incision (clippers > razors).
    
- **Antibiotic prophylaxis**:
    
    - _Clean_ â€“ only if prosthesis/implant.
        
    - _Clean-contaminated / contaminated_ â€“ always.
        
- **Skin prep:**
    
    - Preferred = **alcoholic chlorhexidine**.
        
    - Alternate = **povidone iodine** (less effective if wound is bloody).
        
- **Hand hygiene:**
    
    - **Staff** â€“ wash with soap/water or alcohol rub.
        
    - **Surgeons** â€“ scrub with antiseptic solution (e.g. chlorhexidine).
        

**Clinical Focus:** Shaving causes microabrasions â†’ â†‘ infection risk â†’ use clippers.

---

### **B. Intra-operative**

- Maintain **sterile field**, **sterile gown & gloves**.
    
- **Thorough debridement** of necrotic tissue.
    
- Maintain **tissue oxygenation**, **blood supply**, and **normothermia**.
    
- **Laminar airflow** theatres for joint replacements.
    
- **Negative-pressure dressing** for high-risk wounds.
    
- Close wounds appropriately (interrupted, subcuticular, staples).
    

---

### **C. Post-operative**

- **Aseptic technique** for dressing changes.
    
- **Minimise frequency** of dressing changes.
    
- **Sterile saline** only (â‰¤ 48 h post-op).
    
- Maintain **nutrition** and **glycaemic control**.
    
- Treat other active infections before surgery.
    
- Prevent **pressure sores** via good nursing care.
    
- Early mobilisation â€“ part of **ERAS** (Enhanced Recovery After Surgery).
    

---

## **12. Dressings to Prevent Infection**

|Type|Description / Use|
|---|---|
|**Conventional**|Gauze, tulle gras, non-adhesive fabrics|
|**Occlusive**|Hydrocolloid, polyurethane films, foams|
|**Vacuum-assisted (negative-pressure)**|For wounds healing by secondary intention; high exudate|

**Vacuum dressings (PICO/NPWT):** promote granulation, reduce oedema, and lower SSI risk.

---

## **13. Device-Associated Infections**

Any **indwelling device** may be colonised â†’ biofilm formation.

|Device|Common Pathogens|Notes|
|---|---|---|
|**Vascular catheters**|_Staph. epidermidis_, _S. aureus_, _Candida_|Risk â†‘ with duration of use|
|**Endotracheal tubes**|_Pseudomonas_, _Klebsiella_|Ventilator-associated pneumonia|
|**Urinary catheters**|_E. coli_, _Enterococcus_, _Proteus_|Catheter-associated UTI|

### **Biofilms**

- Microbial communities adhering to device surfaces, encased in matrix.
    
- Protect bacteria from antibiotics & immune response.  
    â†’ Require **device removal** for eradication.
    

---

## **14. Prosthetic Joint Infections (PJI)**

### **Risk Factors**

- Rheumatoid arthritis
    
- Diabetes mellitus
    
- Malnutrition
    
- Obesity
    
- Anaemia
    
- Immunosuppression
    

### **Common Pathogens**

- _Staphylococcus aureus_, _Staph. epidermidis_, _Enterococci_, _Gram-negatives_.
    

### **Diagnosis**

- History + examination.
    
- **Blood culture**, **joint aspiration**, **bone biopsy** for culture.
    
- Raised **CRP (acute phase proteins) / ESR (erythrocyte sedimentation rate)**.
    
- **Imaging:** X-ray, MRI, or nuclear scans.
    

### **Management**

- **Early (â‰¤ 3 wks):** debridement + antibiotics.
    
- **Late / chronic:** prosthesis removal, staged replacement.
    
- **Long-term suppressive therapy** if not operable.
    

---

## **15. Consequences of SSIs**

- Delayed wound healing or **dehiscence**.
    
- Spread to **deep tissues**, **sepsis**, **bacteraemia**.
    
- Secondary infections: **endocarditis**, **osteomyelitis**, **peritonitis**.
    
- **Gas gangrene** (_Clostridium perfringens_), **necrotising fasciitis** (rapidly fatal if untreated).
    

---

## âœ… **Exam Focus Summary**

|Topic|Key Points|
|---|---|
|**Definition & timing**|Within 30 days / 1 year if prosthesis|
|**History**|Lister â€“ antisepsis; Pasteur â€“ germ theory|
|**Clinical signs**|Rubor, calor, tumor, dolor, loss of function|
|**Common pathogens**|_S. aureus_, _E. coli_, _Bacteroides_|
|**Risk factors**|Diabetes, obesity, poor technique, long op|
|**Wound classes**|I (clean) â†’ IV (dirty); infection 2â€“40 %|
|**Pre-op prevention**|MRSA screen, chlorhexidine, antibiotic prophylaxis|
|**Intra-op prevention**|Sterility, haemostasis, laminar flow|
|**Post-op prevention**|Aseptic dressings, minimal handling|
|**Devices / PJIs**|Biofilm â†’ antibiotic resistance; may need removal|

---

## ðŸ©¹ **Clinical Take-Home Messages**

- **Early recognition** = better outcomes.
    
- Always think **source control** (drain, debride, remove device).
    
- Combine **surgical** + **antimicrobial** strategies.
    
- **Laminar airflow** & **negative-pressure dressings** reduce risk in orthopaedic/high-risk surgery.
    
- **Biofilm infections** often require hardware removal.